Summit Therapeutics Inc. (SMMT)
SMMT chart
Everything the smart money is doing in SMMT
This is the SMMT details page members see in the GTA Terminal. Previews below are blurred samples; start a free trial to see the live data.
Option Flows for SMMT
Every unusual options bet in SMMT: size, strikes, expirations and which side the money is on.
Start 14-day free trialAlready a member? Open in the Terminal →Insiders & Congress for SMMT
Every insider and Congress trade in SMMT, the moment it's filed.
Start 14-day free trialAlready a member? Open in the Terminal →Institutions for SMMT
Which hedge funds and institutions are buying and selling SMMT.
Start 14-day free trialAlready a member? Open in the Terminal →Short interest for SMMT
Short interest data for SMMT through 2026-09-30: percent of shares short, days to cover and the squeeze score.
Start 14-day free trialAlready a member? Open in the Terminal →Financials & earnings for SMMT
Eight quarters of revenue, margins and EPS for SMMT, every earnings beat and miss, and conference-call notes.
Start 14-day free trialAlready a member? Open in the Terminal →GTA AI for SMMT
Ask GTA AI for a trade idea on SMMT: bias, entry, stop and target, built from all of the data above.
Start 14-day free trialAlready a member? Open in the Terminal →Sample previews with placeholder values. Then $99/month. Cancel anytime.
Technical summary daily
| Moving average | Simple | Exponential | Signal |
|---|---|---|---|
| MA5 | 17.11 | 16.76 | Sell |
| MA10 | 17.05 | 16.89 | Sell |
| MA20 | 16.88 | 16.75 | Sell |
| MA50 | 15.60 | 16.09 | Buy |
| MA100 | 15.14 | 15.95 | Buy |
| MA200 | 16.34 | 16.54 | Sell |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 44.65 | Sell |
| MACD(12,26) | 0.29 | Buy |
| Stochastic(14) | 13.43 | Oversold |
| ROC(12) | 0.61 | Buy |
Classic pivot points from the last full session. Technical signals are mechanical readings, not recommendations.
Summit Therapeutics Inc. news
Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping NowBeInCrypto · Oct 6, 2026AstraZeneca CEO Pascal Soriot on Summit ivonescimab combosQuartz · Oct 6, 2026SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway CombosZacks · Oct 5, 2026Summit Therapeutics Secures $2 Billion Investment From AstraZenecaMT Newswires · Oct 5, 2026AstraZeneca Completes $2 Billion Equity Investment in Summit TherapeuticsBusiness Wire · Oct 5, 2026How do you see Summit Therapeutics Inc. today?
Results show once a few readers have voted today.
Historical data daily, last 20 sessions
| Date | Price | Open | High | Low | Vol. | Change % |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | 15.70 | 16.76 | 16.79 | 15.61 | 3.41M | -8.32% |
| Oct 12, 2026 | 17.13 | 17.48 | 17.59 | 17.05 | 4.37M | -2.62% |
| Oct 09, 2026 | 17.59 | 17.36 | 17.62 | 16.82 | 5.75M | +2.45% |
| Oct 08, 2026 | 17.17 | 17.61 | 17.64 | 16.80 | 6.17M | -4.35% |
| Oct 07, 2026 | 17.95 | 17.10 | 18.33 | 16.98 | 8.17M | +3.70% |
| Oct 06, 2026 | 17.31 | 17.49 | 17.53 | 16.53 | 5.87M | +0.23% |
| Oct 05, 2026 | 17.27 | 16.97 | 17.62 | 16.44 | 5.28M | +3.07% |
| Oct 02, 2026 | 16.75 | 16.96 | 17.32 | 16.66 | 5.19M | +0.39% |
| Oct 01, 2026 | 16.69 | 16.82 | 17.50 | 16.59 | 7.90M | -1.30% |
| Sep 30, 2026 | 16.91 | 16.59 | 17.72 | 16.17 | 13.06M | +3.17% |
| Sep 29, 2026 | 16.39 | 18.91 | 19.09 | 16.15 | 27.34M | +5.88% |
| Sep 28, 2026 | 15.48 | 15.50 | 15.82 | 15.18 | 6.15M | -0.83% |
| Sep 25, 2026 | 15.61 | 16.45 | 16.58 | 15.55 | 3.80M | -4.70% |
| Sep 24, 2026 | 16.38 | 16.37 | 16.78 | 16.09 | 5.04M | -0.43% |
| Sep 23, 2026 | 16.45 | 17.10 | 17.46 | 16.25 | 3.89M | -3.91% |
| Sep 22, 2026 | 17.12 | 16.97 | 17.50 | 16.79 | 4.62M | +1.30% |
| Sep 21, 2026 | 16.90 | 18.40 | 18.42 | 16.64 | 5.78M | -5.32% |
| Sep 18, 2026 | 17.85 | 17.74 | 17.87 | 17.31 | 13.06M | +0.73% |
| Sep 17, 2026 | 17.72 | 17.73 | 18.10 | 17.42 | 6.13M | +2.43% |
| Sep 16, 2026 | 17.30 | 17.50 | 17.75 | 17.11 | 6.09M | -0.57% |
Full history, intraday charts and downloads are in the GTA Terminal.
About Summit Therapeutics Inc.
Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. Summit was founded in 2003 and the company's shares are listed on the Nasdaq Global Market (symbol "SMMT").
People also watch
FAQ
What is the price of Summit Therapeutics Inc. today?
Summit Therapeutics Inc. (SMMT) last traded at 15.71, down 8.32% on the day.
What is the 52-week range of SMMT?
Over the past 52 weeks SMMT has traded between 12.07 and 29.23.
Is SMMT a buy or a sell?
Daily technical indicators currently read Neutral (4 buy vs 5 sell signals). That is a mechanical reading, not advice.
Get the GTA Daily Brief
The market's biggest stories each morning, plus what options traders, insiders and Congress are doing with their money. Free.